1. Home
  2. GLNG vs APGE Comparison

GLNG vs APGE Comparison

Compare GLNG & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golar Lng Ltd

GLNG

Golar Lng Ltd

HOLD

Current Price

$50.10

Market Cap

5.2B

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.08

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLNG
APGE
Founded
1946
2022
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.7B
IPO Year
2002
2023

Fundamental Metrics

Financial Performance
Metric
GLNG
APGE
Price
$50.10
$134.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$50.63
$109.67
AVG Volume (30 Days)
992.1K
5.4M
Earning Date
11-21-2023
05-12-2026
Dividend Yield
1.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.14
N/A
Revenue Next Year
$8.66
N/A
P/E Ratio
$80.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.02
$34.34
52 Week High
$57.79
$134.35

Technical Indicators

Market Signals
Indicator
GLNG
APGE
Relative Strength Index (RSI) 47.67 80.75
Support Level $48.50 $80.52
Resistance Level $51.99 N/A
Average True Range (ATR) 1.26 0.43
MACD -0.00 -1.69
Stochastic Oscillator 46.19 86.53

Price Performance

Historical Comparison
GLNG
APGE

About GLNG Golar Lng Ltd

Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: